Show simple item record

Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury

dc.contributor.authorKnight, Richard A.en_US
dc.contributor.authorChen-Scarabelli, Carolen_US
dc.contributor.authorYuan, Zhaokanen_US
dc.contributor.authorMcCauley, Roy B.en_US
dc.contributor.authorDi Rezze, J.en_US
dc.contributor.authorScarabelli, Gabriele M.en_US
dc.contributor.authorTownsend, Paul A.en_US
dc.contributor.authorLatchman, Daviden_US
dc.contributor.authorSaravolatz, Louisen_US
dc.contributor.authorFaggian, Giuseppeen_US
dc.contributor.authorMazzucco, Alessandroen_US
dc.contributor.authorChowdrey, Hardial S.en_US
dc.contributor.authorStephanou, Anastasisen_US
dc.contributor.authorScarabelli, Tiziano M.en_US
dc.date.accessioned2016-01-04T20:52:01Z
dc.date.available2016-01-04T20:52:01Z
dc.date.issued2008-03-19en_US
dc.identifier.citationKnight, Richard A.; Chen-Scarabelli, Carol; Yuan, Zhaokan; McCauley, Roy B.; Di Rezze, J.; Scarabelli, Gabriele M.; Townsend, Paul A.; Latchman, David; Saravolatz, Louis; Faggian, Giuseppe; Mazzucco, Alessandro; Chowdrey, Hardial S.; Stephanou, Anastasis; Scarabelli, Tiziano M. (2008). "Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury." FEBS Letters 582(6): 984-990.en_US
dc.identifier.issn0014-5793en_US
dc.identifier.issn1873-3468en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/116364
dc.publisherSpringer-Verlagen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherUrocortinen_US
dc.subject.otherSublethal ischemiaen_US
dc.subject.otherBiomarkeren_US
dc.subject.otherApoptosisen_US
dc.titleCardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injuryen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Cardiology, Veteran Affairs Ann Arbor, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherMedical Molecular Biology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdomen_US
dc.contributor.affiliationotherDivision of Cardiovascular Disease, Department of Internal Medicine, Wayne State University Medical School, Detroit, USAen_US
dc.contributor.affiliationotherDivisione di Cardiochirurgia, Universita’ degli Studi di Verona, Verona, Italyen_US
dc.contributor.affiliationotherDepartment of Biomedical Sciences, University of Westminster, New Cavendish Street, London W1W 6UW, United Kingdomen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/116364/1/feb2s0014579308001439.pdf
dc.identifier.doi10.1016/j.febslet.2008.02.035en_US
dc.identifier.sourceFEBS Lettersen_US
dc.identifier.citedreferenceR.A. Gottlieb, Mitochondrial signaling in apoptosis: mitochondrial daggers to the breaking heart. Basic Res. Cardiol., 98,( 2003 ), 242 – 249.en_US
dc.identifier.citedreferenceB.K. Brar, A.K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R.A. Knight, D.M. Yellon, D.S. Latchman, Urocortin protects against ischaemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem., 275,( 2000 ), 8508 – 8514.en_US
dc.identifier.citedreferenceB.K. Brar, A. Stephanou, R.A. Knight, D.S. Latchman, Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J. Mol. Cell. Cardiol., 34,( 2002 ), 483 – 492.en_US
dc.identifier.citedreferenceT.M. Scarabelli, R.A. Knight, Urocortins: take them to heart. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2,( 2004 ), 335 – 342.en_US
dc.identifier.citedreferenceH. Okumura, N. Nagaya, T. Itoh, I. Okano, J. Hino, K. Mori, Y. Tsukamoto, H. Ishibashi-Ueda, S. Miwa, K. Tambara, S. Toyokuni, C. Yutani, K. Kangawa, Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation, 109,( 2004 ), 242 – 248.en_US
dc.identifier.citedreferenceM.M. Lim, N.O. Tsivkovskaia, Y. Bai, L.Y. Young, R.E. Ryabinin, Distribution of corticotropin-releasing factor and urocortin 1 in the vole brain. Brain Behav. Evol., 68,4( 2006 ), 229 – 240.en_US
dc.identifier.citedreferenceT.M. Scarabelli, R.A. Knight, N.B. Rayment, T.J. Cooper, A. Stephanou, B.K. Brar, K.M. Lawrence, G. Santilli, D.S. Latchman, G.F. Baxter, D.M. Yellon, Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunnel technique enhanced with counterstains. J. Immunol. Meth., 228,( 1999 ), 23 – 28.en_US
dc.identifier.citedreferenceR.A. Donald, E.G. Perry, G.A. Wittert, M. Chapman, J.H. Livesey, M.J. Ellis, M.J. Evans, T. Yandle, E.A. Espiner, The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomy. Clin. Endocrinol., 38,( 1993 ), 609 – 615.en_US
dc.identifier.citedreferenceL.L. Ng, I.W. Loke, R.J. O’Brien, I.B. Squire, J.E. Davies, Plasma urocortin in human systolic heart failure. Clin. Sci. (Lond.), 106,4( 2004 ), 383 – 388.en_US
dc.identifier.citedreferenceT.M. Scarabelli, E. Pasini, A. Stephanou, L. Comini, S. Curello, R. Raddino, R. Ferrari, R. Knight, D.S. Latchman, Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J. Am. Coll. Cardiol., 40,( 2002 ), 155 – 161.en_US
dc.identifier.citedreferenceA.S. Jaffe, H.A. Katus, Acute coronary syndrome biomarkers: the need for more adequate reporting. Circulation, 110,( 2004 ), 104 – 106.en_US
dc.identifier.citedreferenceM.E. Bertrand, M.L. Simoons, K.A.A. Fox, L.C. Wallentin, C.W. Hamm, E. McFadden, P.J. De Feyter, G. Specchia, W. Ruzyllo, Task force on the management of acute coronary syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart. J., 23,( 2003 ), 1809 – 1840.en_US
dc.identifier.citedreferenceC. Patrono, B.A. Peskar, Radioimmunoassay in Basic and Clinical Pharmacology.( 1987 ), Springer-Verlag Heidelbergen_US
dc.identifier.citedreferenceT.M. Scarabelli, E. Pasini, G. Ferrari, M. Ferrari, A. Stephanou, K. Lawrence, P. Townsend, C. Chen-Scarabelli, G. Gitti, L. Saravolatz, D. Latchman, R.A. Knight, J.M. Gardin, Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells. J. Thorac. Cardiovasc. Surg., 128,( 2004 ), 364 – 371.en_US
dc.identifier.citedreferenceB.K. Brar, A. Stephanou, A. Okosi, K.M. Lawrence, R.A. Knight, M.S. Marber, D.S. Latchman, CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol. Cell. Endocrinol., 158,( 1999 ), 55 – 63.en_US
dc.identifier.citedreferenceK.M. Lawrence, T.M. Scarabelli, L. Turtle, A. Chanalaris, P.A. Townsend, C.J. Carroll, M. Hubank, A. Stephanou, R.A. Knight, D.S. Latchman, Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression. FASEB J., 17,15( 2003 ), 2313 – 2315.en_US
dc.identifier.citedreferenceK.M. Lawrence, P.A. Townsend, S.M. Davidson, C.J. Carroll, S. Eaton, M. Hubank, R.A. Knight, A. Stephanou, D.S. Latchman, The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage. Biochem. Biophys. Res. Commun., 321,( 2004 ), 476 – 486.en_US
dc.identifier.citedreferenceK. Lawrence, A. Chanalaris, T.M. Scarabelli, M. Hubanck, E. Pasini, L. Comini, R. Ferrari, A. Stephanou, R.A. Knight, D.D. Latchman, KATP channel gene expression is induced by urocortin and mediates its cardioprotective effect. Circulation, 106,12( 2002 ), 1556 – 1562.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.